European Pharmacopoeia / International harmonisation | News | 07 November 2019 | Strasbourg, France
The EDQM will be holding the Meet the World Pharmacopoeias Symposium in February 2020 in Strasbourg, France, right after the 11th International Meeting of World Pharmacopoeias (IMWP). The aim of this event is to update stakeholders on the achievements and current work programme of the IMWP, giving participants an opportunity to exchange views on pharmacopoeial co-operation and harmonisation.
EDQM / All activities | News | 04 November 2019 | Strasbourg, France
A phishing campaign has been launched from the internet by impersonating an EDQM user in e-mails aimed at infecting the recipients’ computers. These e-mails have been sent from outside the EDQM’s infrastructure, which is why the EDQM has no control over them.
European Pharmacopoeia / International harmonisation | News | 25 October 2019 | Strasbourg, France
The latest face-to-face meeting of the Pharmacopoeial Discussion Group (PDG) [European Pharmacopoeia (Ph. Eur.), Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP)] was hosted by JP in Tokyo, Japan on 1-2 October 2019. WHO participated as observer. The PDG 30th Anniversary Symposium was also held on 3 October 2019.
European Pharmacopoeia / Monograph | News | 23 October 2019 | Strasbourg, France
The European Pharmacopoeia Commission adopted 43 texts related to its new approach to extraneous agents testing of immunological veterinary medicinal products (IVMPs). From starting material to final product, users will now have to follow an overall risk-management approach to ensure they apply the best testing strategies in the context of a consistent manufacturing process.
European Pharmacopoeia / Public enquiry | News | 11 October 2019 | Strasbourg, France
All new texts and texts that have undergone technical revisions are published in Pharmeuropa for public consultation. Users and interested parties are welcome to comment on these drafts.
Products and Services | News | 11 October 2019 | Strasbourg, France
Supplement 10.1 of the European Pharmacopoeia is now available; it will be applicable in 38 European countries as of 1 April 2020.